User profiles for Gyula Szegedi

Gyula Szegedi

University of Debrecen
Verified email at iiibel.dote.hu
Cited by 10010

Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases

…, A Ponyi, T Constantin, G Borgulya, G Szegedi - Medicine, 2004 - journals.lww.com
The idiopathic inflammatory myopathies are characterized by chronic muscle inflammation
and involvement of internal organs, which contribute considerably to the morbidity and …

Association of systemic and thyroid autoimmune diseases

…, G Szűcs, M Zeher, E Bodolay, G Szegedi… - Clinical …, 2006 - Springer
Objective: There are few large cohort studies available on the association of systemic and
thyroid autoimmune diseases. In this study, we wished to determine the association of …

Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and …

…, E Szomják, K Veres, G Szegedi… - The Journal of …, 2008 - jrheum.org
OBJECTIVE: Cardiovascular disease is a leading cause of mortality in rheumatoid arthritis (RA).
Endothelial dysfunction often precedes manifest atherosclerosis. We assessed …

Accelerated atherosclerosis in rheumatoid arthritis

…, S Szanto, L Tamasi, G Szegedi… - Annals of the New …, 2007 - Wiley Online Library
Cardiovascular disease is a leading cause of mortality in rheumatoid arthritis (RA). Endothelial
dysfunction often precedes manifest atherosclerosis. Both traditional, Framingham risk …

Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis

…, H Dér, K Veres, Z Szabó, A Végvári, G Szegedi… - Clinical …, 2009 - Springer
Increased cardiovascular mortality has been associated with rheumatoid arthritis (RA). There
have been reports indicating that tumor necrosis factor blockers may exert favorable but …

Malignant lymphoma-associated autoimmune diseases–a descriptive epidemiological study

L Váróczy, L Gergely, M Zeher, G Szegedi… - Rheumatology …, 2002 - Springer
Lymphoproliferative disorders and autoimmune diseases have some common aspects in their
clinical appearance. We reviewed 940 patient charts with malignant lymphomas to assess …

[HTML][HTML] Vitamin D deficiency in undifferentiated connective tissue disease

…, L Csathy, E Gyimesi, M Zeher, G Szegedi… - Arthritis research & …, 2008 - Springer
Introduction Both experimental and clinical data provide evidence that vitamin D is one of
those important environmental factors that can increase the prevalence of certain autoimmune …

Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment

…, M Zeher, O Timár, P Szodoray, G Szegedi… - Autoimmunity …, 2011 - Elsevier
Numerous autoimmune-inflammatory rheumatic diseases have been associated with
accelerated atherosclerosis or other types of vasculopathy leading to increased cardio- and …

Similarities and differences between pediatric and adult patients with systemic lupus erythematosus

…, Z Siminszky, A Malik, AJ Szabó, G Szegedi… - Lupus, 2015 - journals.sagepub.com
Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease with highest
prevalence among women of childbearing age. However, children younger than 16 years also …

Assessment of subclinical vascular disease associated with ankylosing spondylitis

…, J Kappelmayer, ZG Némethné, G Szegedi… - The Journal of …, 2011 - jrheum.org
Objective. Studies indicate that ankylosing spondylitis (AS), as well as rheumatoid arthritis,
may be associated with accelerated atherosclerosis and vascular disease. We assessed …